News

Deal Announcements

BioAegis Therapeutics Nets $3 Million Venture Capital

Tuesday, February 12, 2013 5:34:00 AM PDT | VentureDeal
   Boston, Massachusetts  --  Biotechnology company BioAegis Therapeutics has received $3 million in new venture capital equity financing.

BioAegis is developing therapeutics that will restore depleted levels of plasma gelsolin.

Investors in the round were not disclosed.

The company said it would use the funding proceeds to fund continued development for its lead product candidate.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1